药品注册申请号:208005
申请类型:ANDA (仿制药申请)
申请人:MYLAN
申请人全名:MYLAN PHARMACEUTICALS INC
产品信息
产品号商品名活性成分剂型/给药途径规格/剂量参比药物(RLD)生物等效参考标准(RS)治疗等效代码该申请号批准日期该产品号批准日期市场状态
001 FINGOLIMOD HYDROCHLORIDE FINGOLIMOD HYDROCHLORIDE CAPSULE;ORAL EQ 0.5MG BASE No No AB 2021/01/19 2021/01/19 Prescription
批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期提交号审批结论申请内容分类审评优先级;罕用药状态通知信、审评文件、说明书、包装标签备注
2024/04/15 SUPPL-5(补充) Approval Labeling STANDARD
2024/04/15 SUPPL-4(补充) Approval Labeling STANDARD
2021/01/19 ORIG-1(原始申请) Approval STANDARD
与本品相关的专利信息(来自FDA橙皮书Orange Book)
关联产品号专利号专利过期日是否物质专利是否产品专利专利用途代码撤销请求提交日期专利下载备注
与本品相关的市场独占权保护信息
关联产品号独占权代码失效日期备注
与本品治疗等效的药品
活性成分:FINGOLIMOD HYDROCHLORIDE 剂型/给药途径:CAPSULE;ORAL 规格:EQ 0.5MG BASE 治疗等效代码:AB
申请号产品号申请类型商品名活性成分剂型/给药途径规格市场状态RLDRSTE Code产品号批准日期申请人
022527 001 NDA GILENYA FINGOLIMOD HYDROCHLORIDE CAPSULE;ORAL EQ 0.5MG BASE Prescription Yes Yes AB 2010/09/21 NOVARTIS
207979 001 ANDA FINGOLIMOD HYDROCHLORIDE FINGOLIMOD HYDROCHLORIDE CAPSULE;ORAL EQ 0.5MG BASE Prescription No No AB 2019/12/04 BIOCON LTD
208014 001 ANDA FINGOLIMOD HYDROCHLORIDE FINGOLIMOD HYDROCHLORIDE CAPSULE;ORAL EQ 0.5MG BASE Prescription No No AB 2019/12/04 SUN PHARM
207933 001 ANDA FINGOLIMOD HYDROCHLORIDE FINGOLIMOD HYDROCHLORIDE CAPSULE;ORAL EQ 0.5MG BASE Prescription No No AB 2020/05/18 HETERO LABS LTD V
207985 001 ANDA FINGOLIMOD HYDROCHLORIDE FINGOLIMOD HYDROCHLORIDE CAPSULE;ORAL EQ 0.5MG BASE Prescription No No AB 2020/06/18 GLENMARK PHARMS LTD
208008 001 ANDA FINGOLIMOD HYDROCHLORIDE FINGOLIMOD HYDROCHLORIDE CAPSULE;ORAL EQ 0.5MG BASE Prescription No No AB 2020/07/02 TEVA PHARMS USA
207994 001 ANDA FINGOLIMOD HYDROCHLORIDE FINGOLIMOD HYDROCHLORIDE CAPSULE;ORAL EQ 0.5MG BASE Prescription No No AB 2020/10/14 ZYDUS PHARMS
207991 001 ANDA FINGOLIMOD HYDROCHLORIDE FINGOLIMOD HYDROCHLORIDE CAPSULE;ORAL EQ 0.5MG BASE Prescription No No AB 2020/10/28 ACCORD HLTHCARE
207993 001 ANDA FINGOLIMOD HYDROCHLORIDE FINGOLIMOD HYDROCHLORIDE CAPSULE;ORAL EQ 0.5MG BASE Prescription No No AB 2020/12/18 APOTEX
208004 001 ANDA FINGOLIMOD HYDROCHLORIDE FINGOLIMOD HYDROCHLORIDE CAPSULE;ORAL EQ 0.5MG BASE Prescription No No AB 2020/12/30 ALKEM LABS LTD
208005 001 ANDA FINGOLIMOD HYDROCHLORIDE FINGOLIMOD HYDROCHLORIDE CAPSULE;ORAL EQ 0.5MG BASE Prescription No No AB 2021/01/19 MYLAN
208000 001 ANDA FINGOLIMOD HYDROCHLORIDE FINGOLIMOD HYDROCHLORIDE CAPSULE;ORAL EQ 0.5MG BASE Prescription No No AB 2021/03/05 DR REDDYS
207939 001 ANDA FINGOLIMOD HYDROCHLORIDE FINGOLIMOD HYDROCHLORIDE CAPSULE;ORAL EQ 0.5MG BASE Prescription No No AB 2021/11/10 HEC PHARM CO LTD
208003 001 ANDA FINGOLIMOD HYDROCHLORIDE FINGOLIMOD HYDROCHLORIDE CAPSULE;ORAL EQ 0.5MG BASE Prescription No No AB 2022/09/07 PRINSTON INC
210252 001 ANDA FINGOLIMOD HYDROCHLORIDE FINGOLIMOD HYDROCHLORIDE CAPSULE;ORAL EQ 0.5MG BASE Prescription No No AB 2023/05/24 BIONPHARMA
207945 001 ANDA FINGOLIMOD HYDROCHLORIDE FINGOLIMOD HYDROCHLORIDE CAPSULE;ORAL EQ 0.5MG BASE Prescription No No AB 2023/12/06 EZRA VENTURES
207983 001 ANDA FINGOLIMOD HYDROCHLORIDE FINGOLIMOD HYDROCHLORIDE CAPSULE;ORAL EQ 0.5MG BASE Prescription No No AB 2024/02/28 AUROBINDO PHARMA LTD
更多信息
药品NDC数据与药品包装、标签说明书
©2006-2024 DrugFuture->U.S. FDA Drugs Database